Abstract:A cancer predisposition mutation can occur during post-zygotic stages resulting in a mosaic mutation pattern across tissues. Mosaic germline mutations such as those affecting RB1, TP53 and AKT1 are important for clinical testing. However, it is challenging to detect mosaic mutation by genome-wide sequencing approaches as a mutant allele present at a low fraction in a germline sample can be caused by either tumor-in-normal contamination or mosaicism. Here we propose a two-step analytical approach to distinguish between these two possibilities. The first involves assessing the level of tumor-in-normal contamination using all clonal somatic mutations identified through the analysis of tumor purity and chromosome ploidy. The second step determines the probability of mosaicism for a candidate variant by calculating the binomial probability of its mutant allele fraction (MAF) under the contamination hypothesis. We applied this process to 1,172 paired tumor-normal pediatric cancer samples analyzed by whole-genome or whole-exome sequencing. Six mosaic variants were identified, including three pathogenic TP53 mutations with a mutant allele fractions (MAF) ranging from 0.2 to 0.3, one RB1 mutation in a retinoblastoma case with a MAF of 0.08, one IDH1 p.R132H mutation in an acute myeloid leukemiaý case with a MAF of 0.21, and one mosaic RYR2 p.E1690D mutation in an osteosarcoma case with a MAF of 0.11. At the same time, we were able to reject three candidate TP53 variants caused by contamination with MAFs ranging from 0.06 to 0.33. All predicted mosaic mutations were verified by ultra deep sequencing at 10,000X coverage. This experience demonstrates the feasibility of detecting germline mosaicism from whole-genome or whole-exome sequencing of paired tumor-normal samples and would caution accurate analysis of tumor-in-normal contamination when evaluating candidate germline mosaicism. Citation Format: Xiaotu Ma, Donald Yergeau, Bhavin Vadodaria, Joy Nakitandwe, John Easton, Sheila Shurtleff, Jinghui Zhang. Analysis of cancer-initiating mosaic mutation in germline samples of pediatric cancer patients by next generation sequencing. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 851.

Accurate detection of mosaic variants in sequencing data without matched controls

MosaicHunter: Accurate Detection of Postzygotic Single-Nucleotide Mosaicism Through Next-Generation Sequencing of Unpaired, Trio, and Paired Samples

DeepMosaic: Control-independent mosaic single nucleotide variant detection using deep convolutional neural networks

Control-independent mosaic single nucleotide variant detection with DeepMosaic

A robust benchmark for detecting low-frequency variants in the HG002 Genome In A Bottle NIST reference material.

Comprehensive identification of somatic nucleotide variants in human brain tissue

Detection of Mosaic Absence of Heterozygosity (AOH) Using Low-Pass Whole Genome Sequencing in Prenatal Diagnosis: A Preliminary Report

A Clinical Survey of Mosaic Single Nucleotide Variants in Disease-Causing Genes Detected by Exome Sequencing.

Detecting Somatic Mutations Without Matched Normal Samples Using Long Reads

A personalized multi-platform assessment of somatic mosaicism in the human frontal cortex

Genome-wide detection of somatic mosaicism at short tandem repeats

Mitosomatic: a Tool for Accurate Identification of Mitochondrial DNA Somatic Mutations Without Paired Controls

iFlpMosaics enable the multispectral barcoding and high-throughput comparative analysis of mutant and wild-type cells

Resolving the chromatin impact of mosaic variants with targeted Fiber-seq

Abstract 851: Analysis of Cancer-Initiating Mosaic Mutation in Germline Samples of Pediatric Cancer Patients by Next Generation Sequencing

Postzygotic Single-Nucleotide Mosaicisms in Whole-Genome Sequences of Clinically Unremarkable Individuals.

mosaicMPI: a framework for modular data integration across cohorts and -omics modalities

Robust identification of extrachromosomal DNA and genetic variants using multiple genetic abnormality sequencing (MGA-Seq)

High efficiency error suppression for accurate detection of low-frequency variants

Detection of mosaic and population-level structural variants with Sniffles2

Snpdetector: A Software Tool for Sensitive and Accurate Snp Detection